News

As we honor Counseling Awareness Month, Relief Mental Health recognizes the critical role that therapy plays in helping ...
The trailer for the 27th series of South Park has dropped and it appears to include a few swipes at Elon Musk, in regards to ...
Internal Family Systems has been wholeheartedly embraced by celebrities and desperate patients alike. But is it a science—or ...
Discover how the brain's most abundant neurotransmitter, glutamate, is revolutionizing psychiatry and offering new hope for ...
The trailer for Season 27 of South Park has been released, and the animated satirical sitcom appears to have a new target: Elon Musk. Newsweek has reached out to X outside of normal working hours via ...
The FDA has approved Janssen’s antidepressant nasal spray Spravato ... The drug is the first ketamine-based medicine approved to treat depression. Ketamine has long been seen as a potential ...
Tasman Therapeutics, Inc. (Tasman) has announced plans to raise $175 million in Series A funding to support the late-stage clinical development and eventual commercialization of R-107. This innovative ...
Through my extensive experience in biopharmaceuticals, I recognized ketamine's many positive properties. However, current treatments—administered intravenously or via nasal spray in clinics ...
Authorities in New South Wales and Victoria have been warning the public about worrying cases of heroin overdoses after ...
an intranasal formulation of racemic ketamine. BeiGene has decided to stop the development of its TIGIT-targeting drug ociperlimab in yet another setback for the drug class.